A Phase II Study of Docetaxel and Vinorelbine Plus Filgrastim for HER-2 Negative, Stage IV Breast Cancer: SWOG S0102
Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-013-2797-2
Full Text
Open PDFAbstract
Available in full text
Date
December 19, 2013
Authors
Publisher
Springer Science and Business Media LLC